Delhi NCR Healthtech Startups: $917 Mn Raised in H1 2026
Discover how Delhi NCR's healthtech startups raised $917 Mn in H1 2026, down 39% YoY but with a 16% rise in deal count. Key highlights and top-funded companies.
LazyFounders
Delhi NCR Healthtech Startups: $917 Mn Raised in H1 2026
30 SEC SUMMARY
In H1 2026, Delhi NCR's healthtech startups raised $917 Mn across 134 deals, marking a 39% drop in value year-on-year but a 16% increase in deal count. Key players include Clove Dental, BeatO, and NirogStreet. The sector remains robust with a projected CAGR of 39% to $37 Bn by 2030.
TABLE OF CONTENTS
- Introduction
- Delhi NCR Startup Funding Overview
- Healthtech Sector Performance
- Top Funded Healthtech Startups
- Future Projections
- FAQs
- Conclusion
- Call-to-Action
Introduction
The Delhi NCR region continues to be a hotbed for startup activity, particularly in the healthtech sector. Despite a year-on-year decline in funding value, the number of deals has increased, indicating a dynamic and evolving ecosystem. This article delves into the specifics of healthtech funding in Delhi NCR for H1 2026, highlighting key players and future trends.
Delhi NCR Startup Funding Overview
Delhi NCR raised $917 Mn across 134 deals in H1 2026, a 39% decrease in funding value compared to the same period in 2025 but a 16% rise in deal count. This contrasts with the national total of $5.2 Bn across 501 deals. Healthtech startups in New Delhi, which hosts around 80 healthtech startups, are particularly noteworthy.
Healthtech Sector Performance
Healthtech remains a significant sector in India, ranking fourth in 2024 with $0.7 Bn across 78 deals. Over the past decade, Indian healthtech has raised over $7 Bn across 886 deals. In 2025, the sector saw $700 Mn across 54 deals, down from 78 deals in 2024. Datalabs projects a 39% CAGR to $37 Bn by 2030.
Growth Drivers
The growth in New Delhi's healthtech ecosystem is fueled by post-pandemic trends such as wearable adoption, preventive care, and teleconsultations. Notable companies include Clove Dental, BeatO, Eye Mantra, Hospals, and NirogStreet. Newer AI-led ventures like Sychedelic, which raised $3.5 Mn for AI-powered mental wellness headphones, are also emerging.
Top Funded Healthtech Startups
Here are the top 30 funded healthtech startups in New Delhi, ranked by total funding raised:
| Rank | Company | Total Funding (Mn) | Last Funding Stage |
|---|---|---|---|
| 1 | Clove Dental | $117.00 | Series E |
| 2 | BeatO | $47.60 | Series B |
| 3 | NirogStreet | $36.80 | Convertible Note |
| 4 | Cygnus Medicare | $27.87 | Debt Financing |
| 5 | SaveIN | $13.40 | Undisclosed |
| 6 | Nivaan Care | $11.30 | Series A |
| 7 | Dentalkart.com | $10.04 | Undisclosed |
| 8 | Eye Mantra | $10.00 | Corporate Round |
| 9 | Consure Medical | $5.92 | Series B |
| 10 | Glamyo Health | $5.50 | Series B |
Future Projections
The healthtech sector is expected to grow at a 39% CAGR to $37 Bn by 2030. This growth is driven by increasing adoption of digital health solutions and advancements in AI and telemedicine.
FAQs
What is the current state of healthtech funding in Delhi NCR?
Healthtech funding in Delhi NCR saw $917 Mn across 134 deals in H1 2026, a 39% decrease in value but a 16% increase in deal count compared to H1 2025.
Which companies lead in healthtech funding in New Delhi?
Clove Dental, BeatO, and NirogStreet are the top-funded healthtech startups in New Delhi.
What are the growth drivers for healthtech in Delhi NCR?
Growth is driven by post-pandemic trends including wearable adoption, preventive care, and teleconsultations.
Conclusion
The healthtech sector in Delhi NCR remains robust despite a year-on-year decline in funding value. With a projected CAGR of 39% to $37 Bn by 2030, the sector is poised for significant growth, driven by technological advancements and increasing adoption of digital health solutions.
Call-to-Action
Ready to explore more about the thriving healthtech startups in Delhi NCR? Visit blogy.in for more insights and updates.
Sources
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.
